James Emanuel Blessman Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15400 W Mcnichols Rd, Detroit, MI 48235 Phone: 313-340-4300 |
Dr. Jacob James Manteuffel, M.D. Family Medicine - Addiction Medicine Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 |
Fatima Younus, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3300 |
Dr. David John Gryniewicz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5716 Michigan Ave, Detroit, MI 48210 Phone: 313-554-0485 |
Dr. Curtis Davis, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd Ste 450, Detroit, MI 48202 Phone: 770-316-0559 |
Amin Abu Khatir, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 22101 Moross Rd, Detroit, MI 48236 Phone: 586-777-2050 |
Dr. Aniebietabasi Okon-umoren, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2799 W Grand Boulevard, Detroit, MI 48202 Phone: 313-916-1601 Fax: 313-916-2018 |
Dr. Frank F Lanzilote, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16226 Grand River Ave, Detroit, MI 48227 Phone: 313-836-5490 Fax: 313-836-5224 |
Felix Mario Valbuena Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5635 W Fort St, Detroit, MI 48209 Phone: 313-849-3920 Fax: 313-849-0824 |
Maricela Castillo Mackenzie, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5635 W Fort St, Detroit, MI 48209 Phone: 313-849-3920 |
News Archive
To determine whether SARS-CoV-2 resulted from a natural spillover into humans, researchers discuss the veracity of early SARS-CoV-2 lineages.
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Synthetech, Inc. today announced financial results for the first quarter of fiscal 2011, which ended June 30, 2010. Revenue for the quarter was $2.0 million, a 56% decrease compared to revenue of $4.7 million in the first quarter of fiscal 2010. The operating loss for the current quarter was $727,000, compared to operating income of $1.0 million for the same period last year. The net loss for the current quarter was $763,000, or $0.05 per basic share, compared to last year's first quarter net income of $969,000, or $0.07 per basic share.
Noting that the Global Health Initiative (GHI) leadership and the three core entities of GHI - USAID, the Centers for Disease Control and Prevention (CDC) and PEPFAR - announced the closure of the GHI office and an end to the initiative's current phase on July 3, Serra Sippel, president of the Center for Health and Gender Equity, writes in the Huffington Post's "Politics" blog that "the three agencies will be responsible for ensuring that the GHI principles are implemented in the field to achieve global health goals."
If you don't know how a human cell is supposed to work, it's hard to offer a good explanation when the cell goes haywire - as it does in cancer. That's why a Florida State University College of Medicine researcher has been awarded a $1.2 million grant to explore the role of centrosomes and cilia in cell division and development and their connections to human disease.
› Verified 5 days ago